FACS analysis revealed that four out of four of the representative lung cancer cell lines contained ALDHbright cells and exhibited increased number of ALDHbright cells upon cisplatin treatment, according to the chemoresistant nature of the ALDH expressing cells (96 hrs, p < 0.05; Figure 3D). This evidence concerns the gene LDHA and lung carcinoma.